التفاصيل البيبلوغرافية
| العنوان: |
GLIS2 and CCND1 expression levels in breast cancer patients. |
| المؤلفون: |
Sadeghi, Minoosh, Gholizadeh, Majid, Safataj, Neda, Tahmasebivand, Mahsa, Mohajeri, Gholamreza, Lotfi, Hajie, Bostanabad, Saber Yari, Safar, Behnaz, Salehi, Mansoor |
| المصدر: |
Breast Disease; 2023, Vol. 42 Issue 1, p251-259, 9p |
| مستخلص: |
BACKGROUND: Breast cancer (BC) is the most prevalent cancer in women, with increasing incidence and death rates in recent years. Disruptions of different signaling pathways partially cause breast cancer. Hence, different genes through particular pathways are involved in BC tumorigenesis. METHODS: In this study, we evaluated the expression level of GLIS2 and CCND1 genes in 50 patients. Also, in-silico analyses were used to enrich related signaling pathways involving the mentioned genes. RESULTS: The results showed an increased expression level of Cyclin D1 and decreased expression level of GLIS2 in BC patients. Moreover, a relationship between aberrant expression levels of GLIS2 and CCND1 and BC development was determined. CONCLUSION: These observations could help uncover new therapeutic targets for treating patients with BC in the progressive stage. [ABSTRACT FROM AUTHOR] |
|
Copyright of Breast Disease is the property of IOS Press and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
